Skip to main content
Premium Trial:

Request an Annual Quote

A. Barry Rand, Sue Rataj

Agilent Technologies announced changes to its board with the resignation of A. Barry Rand and the election of Sue Rataj. 

Rand's resignation is effective Oct. 31. He has been a board member since 2000 and serves on the compensation committee and nominating/corporate governance committee. His departure is not the result of any disagreement with the firm regarding its operations, policies, or practices, Agilent said.

Meanwhile, Rataj joined the board effective Sept. 15. She was chief executive of BP's global petrochemicals business before retiring in April 2011. Before that, she was a group president at BP. Following her retirement from the firm, Rataj joined the board of Cabot and the supervisory board of Bayer.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.